Current Caredx reports a gross margin of 70.6%, an operating margin of 23.6%, an EBITDA margin of 27.8%, and a net margin of 24.2%. All measured margins increased year over year, led by operating margin with an increase of 10.1 percentage points.
Over the last 3 years, Caredx's margins averaged 66.67% gross, -17.42% operating, -11.13% EBITDA, and -13.96% net. Compared with their three-year averages, all four current margins are higher.
Year over year, gross, operating, EBITDA, and net margins all increased, with operating margin showing the largest gain at 10.1 percentage points.
Across the last 3 years, Caredx's gross margin averaged 66.67%. The current gross margin stands at 70.6%, 3.9 percentage points above its three-year average. Gross margin was highest at 70.6% in Jun 2026 and lowest at 62.9% in Mar 2024.
Across the last 3 years, Caredx's operating margin stood at -17.42%. The current operating margin stands at 23.6%, 41 percentage points above its three-year average. Operating margin was highest at 23.6% in Jun 2026 and lowest at -73.3% in Mar 2024.
Caredx recorded an average EBITDA margin of -11.13% across the last 3 years. Caredx currently reports an EBITDA margin of 27.8%, 38.9 percentage points above its three-year average. During this period, EBITDA margin reached a high of 27.8% in Jun 2026 and a low of -65% in Dec 2023.
Caredx's net margin averaged -13.96% during the last 3 years. Caredx currently reports a net margin of 24.2%, 38.2 percentage points above its three-year average. Over the last 3 years, Caredx's net margin peaked at 24.2% in Jun 2026 and reached a low of -67.9% in Dec 2023.
Caredx's gross margin of 70.6% is higher than the Healthcare sector and the industry average. But in comparison with the Healthcare sector average of 68.3%, Caredx's gross margin is only 3.4% higher.
For the period ending Jun 30, 2026, CDNA recorded a gross margin of 70.6%.
The current operating margin for CDNA is 23.6% as of Jun 30, 2026.
As of Jun 30, 2026, CDNA has an EBITDA margin of 27.8%.
As of Jun 30, 2026, CDNA has a net margin of 24.2%.
Over the past 3 years, CDNA reported average margins of 66.7% gross, -17.4% operating, -11.1% EBITDA, and -14.0% net.
In the last 5 years, the highest margins reported by CDNA were 70.6% gross in Jun 2026, 23.6% operating in Jun 2026, 27.8% EBITDA in Jun 2026, and 24.2% net in Jun 2026.
Within the 5-year period, CDNA recorded its lowest margins at 62.9% gross in Mar 2024, -73.3% operating in Mar 2024, -65% EBITDA in Dec 2023, and -67.9% net in Dec 2023.